Chai Discovery raises $400 million to advance AI-designed drug discovery
Summary
Chai Discovery raised $400 million in Series C funding at a $3.8 billion valuation. The company plans to expand its molecular design platform across the pharmaceutical industry. Index Ventures led the round, and several major venture firms joined as new or existing backers. The news also highlights Chai Discovery’s growing role in AI-driven drug discovery partnerships with large pharma companies.
Funding
Amount
$400.0M
Total raised
Date
July 15, 2026
Announcement date
Investors
Thrive Capital, Menlo Ventures, Kleiner Perkins Caufield & Byers, Baillie Gifford, Battery Ventures, Sapphire Ventures, LLC, Bain Capital Ventures, Oak HC/FT, General Catalyst
Lead investors
Company
chaidiscovery.com
Funded company
Classifications
industries
No industries detected
applications
Software Design & Development
AskAI Classifications
Labels
Software Development
Blockchain Software
Web3 Technology
Linked Companies
Edenia
$1M to $5M